Skip to site menu Skip to page content

Eligen® Technology Mechanism of Action

By Emisphere Technologies
Emisphere's Eligen® Technology binds a delivery agent with a therapeutic compound without alternation. This process occurs when both agent and compound are in close proximity. After oral ingestion, the drug-carrier combination comes in contact with stomach/intestinal membrane. Delivery agent chaperones compound through the gastrointestinal (GI) membrane, with weak intermolecular forces allowing for separation. Download this free whitepaper, complete with an insightful diagram, to find out more.
Enter your details below to view the free white paper

By downloading this whitepaper, you acknowledge that GlobalData may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our Privacy Policy for more information about our services, how GlobalData may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Related Content